ClinicalTrials.Veeva

Menu

Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency

G

Guangzhou University of Traditional Chinese Medicine

Status and phase

Completed
Phase 2
Phase 1

Conditions

Primary Ovarian Insufficiency

Treatments

Other: Chinese medicine granules (HuYang Yang Kun Formula)
Dietary Supplement: dehydroepiandrosterone

Study type

Interventional

Funder types

Other

Identifiers

NCT02794948
YN2014TS06

Details and patient eligibility

About

The purpose of this research is providing valuable traditional chinese medicine theory and formula in treating Primary Ovarian insufficiency.

Full description

Primary ovarian insufficiency is a problem that is to be solved urgently in the field of reproductive endocrine. According to the basic theory of traditional Chinese Medicine and clinical experience, investigators developed a Chinese medicine formula(Hu yang yang kun,Hyyk). This research is designed according to the principle of randomized double blind control and evaluated the effectiveness and safety of Hyyk, hope to provide a kind of effective medicine in treating primary ovarian insufficiency.

Enrollment

48 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 18-40
  2. Menstrual cycle change more than 7 days at least 2 times,amenorrhea less than 6 months.
  3. Sex hormone:bFSH>10u/L;or E2>80pg/ml.
  4. AMH<1ng/ml.
  5. Informed consent and truthfully answer the question.

Exclusion criteria

  1. Dose not meet the inclusion criteria.
  2. Genital tract malformation,congenital germinal aplasia, uterine amenorrhea and so on organic disease.
  3. Endocrine diseases such Polycystic ovary syndrome、hyperprolactinemia 、dysfunctional uterine bleeding、low gonadotropin menstrual disorders and hyperthyreosis
  4. Autoimmune disease patients:Hashimoto's thyroiditis,SLE,Primary chronic adrenal cortical insufficiency,Asthenic bulbar paralysis,Arthritis deformans,Idiopathic thrombocytopenic purpura, type I diabetes and so on.
  5. Someone who have the following gynecological operation history: oophorocystectomy,ovarian drilling,wedgeshaped oophorectomy,adnexectomy,tubal resection,ligation of oviduct,pelvic abscess surgery,uterine arterial embolization.
  6. Someone who have used reproductive toxicity drugs: tripterygium wilfordii,tripterygium hypoglaucum hutch,chemotherapeutics and so on.
  7. A family history of ovarian failure.
  8. Have receive hormone therapy in recent 3 months.
  9. Pregnant or lactating women.
  10. with serious heart,liver and kidney disease
  11. With severe psychiatric disorders .
  12. Have participated in other clinical trials in 3 months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

48 participants in 2 patient groups

Chinese Medicine intervention
Experimental group
Description:
Chinese medicine HuYang Yang Kun Formula 1 capsule every time per day for 3 day per month, DHEA(dehydroepiandrosterone) placebo 1 sack every time, twice a day for three months
Treatment:
Other: Chinese medicine granules (HuYang Yang Kun Formula)
Western intervention
Active Comparator group
Description:
DHEA(dehydroepiandrosterone) 1 sack every time twice a day for three months. Chinese medicine formula granules placebo 1 capsule every time per day for 3 day per month.
Treatment:
Dietary Supplement: dehydroepiandrosterone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems